GMVDF (G Medical Innovations Holdings) Total Payout Yield %: 0.00 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMVDF G Medical Innovations Holdings Ltd GMVDF
12 GF Score
Price $0.00
View Full Analysis

What is G Medical Innovations Holdings Total Payout Yield %?

G Medical Innovations Holdings GMVDF 12 Total Payout Yield % is 0.00 as of Aug. 02, 2026. GuruFocus rates GMVDF with a GF Score™ of 12/100.

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

G Medical Innovations Holdings's current Total Payout Yield % is 0.00%.


G Medical Innovations Holdings Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


G Medical Innovations Holdings Total Payout Yield % Related Terms


G Medical Innovations Holdings Total Payout Yield % Historical Data

* Premium members only.

The historical data trend for G Medical Innovations Holdings's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings Total Payout Yield % Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Payout Yield %
Get a 7-Day Free Trial -0.01 0.00 -0.01 -59.16 -66.05

G Medical Innovations Holdings Semi-Annual Data
Sep16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Total Payout Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -54.25 -0.03 -45.25 0.72

GMVDF vs WHSI, ISRG, BDX: Total Payout Yield % Comparison

For the Medical Devices subindustry, G Medical Innovations Holdings's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings Total Payout Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Total Payout Yield % falls into.


GMVDF
12GF Score
G Medical Innovations Holdings Ltd GMVDF
Total Payout Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G Medical Innovations Holdings Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

G Medical Innovations Holdings's Total Payout Yield % for the fiscal year that ended in Dec. 2022 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (-0.121 + 3.442 + 0) / 5.02824
=-66.05%

G Medical Innovations Holdings's annualized Total Payout Yield % for the quarter that ended in Dec. 2022 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + -0.018 + 0) * 2 / 5.02824
=0.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Yield % →
What does a Total Payout Yield % of 0.00 mean?
G Medical Innovations Holdings (GMVDF) has a Total Payout Yield % of 0.00 as of Aug. 02, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on G Medical Innovations Holdings and its competitors.
Is G Medical Innovations Holdings' Total Payout Yield % too high?
G Medical Innovations Holdings' current Total Payout Yield % is 0.00. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' Total Payout Yield % compare to WHSI and ISRG?
G Medical Innovations Holdings' Total Payout Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Medical Devices & Instruments company?
A good Total Payout Yield % depends on the Medical Devices & Instruments industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on G Medical Innovations Holdings and its competitors. G Medical Innovations Holdings's current Total Payout Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current Total Payout Yield % of 0.00. The current Total Payout Yield % is 0.00. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current Total Payout Yield % is 0.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G Medical Innovations Holdings Business Description

Address 5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score

Get the complete analysis for GMVDF

Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price